There is a dedicated investor sector in Biotechs, which ANP was always been part of, so it was able to get that general liquidity from the sector trading it as part of a portfolio.
PNO has never made that pool. Not enough IP around it's so called wonder pain drug tripeptofen. This is the missing link, why have they spent no money on proving up tripeptofen!!!? now PNO needs a partner and partners don't usually get involved until phase 2 and even three have been completed!, we havn't even thought about phase 1 yet!!..
Subsequently this stock is owned only by retail, and will only sink lower unless PNO gets a development partner. AND do we really believe Thermalife can sell 30,000 tubes a quarter and break even before it runs out of money?? (it's currently at 752 tubes.)
GL
Add to My Watchlist
What is My Watchlist?